Nasopharyngeal and oropharyngeal swab with real-time reverse transcriptase-polymerase chain reaction (RT-PCR) test History of underlying medical condition: DM, HTNĪbdominal signs and symptoms: nausea, vomiting, pain, distention, diarrhea, and constipationĬlinical examination: Complete clinical examination was done for each patient

Suspicious chest symptoms: fever, dry cough, tremors Recent contact with confirmed COVID-19 patient Recent travel history especially to known epidemic disease territories Thorough history taking including the following: This is a retrospective study analysis of 30 intensive care patients with confirmed COVID-19 infection and presented with abdominal signs and symptoms and/or abnormal visceral laboratory tests.Įach patient was subjected to the following: Īlthough there are multiple articles evaluated the imaging findings in HRCT of COVID-19 patients that helped in understanding the disease course and potential complications in the chest, yet there are-to our knowledge-limited data about the abdominal imaging findings of the course and potential abdominal complications of COVID-19. Īs case numbers have increased worldwide, gastro-intestinal symptoms like diarrhea, constipation, abdominal pain, and vomiting have been increased these symptoms are associated with positive laboratory results including abnormal liver function tests, renal function tests, and D-Dimer levels. Early radiological studies focused on chest imaging with classical high-resolution CT (HRCT) findings of peripheral patches of ground-glass densities with or without consolidations with bilateral basal predominance, organizing pneumonia pattern, crazy paving, mild bronchiectasis, and vascular engorgement may be encountered as well. The classical symptoms of COVID-19 are dry cough and fever and the diagnosis is confirmed by real-time reverse transcription-polymerase chain reaction (RT-PCR) testing for SARS-Cov-2 nucleic acid. The WHO recognized the coronavirus disease 2019 (COVID-19) as a worldwide pandemic on Ma. The pneumonic disease caused by this virus is called coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO), on January 30, 2020, the WHO declared a global public health emergency against the outbreak of COVID-19. The novel coronavirus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses. In December 2019, a large outbreak of a novel coronavirus infection occurred in Wuhan, China. Hepatobiliary dysfunction as well as nephropathy was the most common imaging findings.

ConclusionĪbdominal sonographic imaging was often performed for inpatients with COVID-19. CT examination when indicated (in our study to assess hematomas for active extravasation and to assess bowel obstruction and its level). The most common sonographic observation was hepatomegaly ( n, 23/41, 56%) and biliary system disease ( n, 17/41, 41.4%) the imaging findings were correlated with the clinical and laboratory data. Of the 30 patients, 26 were males (86.66%), and 4 were females (13.3%), the average age of the patients was 57.7 years old.

Resultsįorty-one sonographic examinations were done for 30 confirmed COVID-intensive care patients presented with abdominal symptoms. The pneumonic disease caused by this virus is called coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO).Īs case numbers have increased worldwide, gastro-intestinal symptoms like diarrhea, constipation, abdominal pain, and vomiting have been increased, these symptoms associated with positive laboratory results including abnormal liver function tests, renal function tests, and D-Dimer levels.Īlthough there are multiple articles evaluated the imaging findings in HRCT of COVID-19 patients that helped in understanding the disease course and potential complications in the chest, yet there are-to our knowledge-limited data about the abdominal imaging findings of the course and potential abdominal complications of COVID-19 notably in the intensive care units (ICU).

Sonogram abdomen